类风湿关节炎肿胀关节缓解速度远快于患者报告结局:OBRI注册研究
该研究基于加拿大OBRI注册队列的986例RA患者,评估基于CDAI或SJC28定义缓解后患者报告结局(PROs)的滞后时间。结果显示,达到SJC28≤1的中位时间仅12.5个月,而PtGA≤1cm、疼痛≤1cm和疲劳≤1cm分别需39.6、54.7和42.6个月,PROs缓解显著滞后于肿胀关节缓解。
要点
- 肿胀关节数缓解远快于患者报告结局,PROs缓解滞后可达30个月以上。
- 以复合指标为目标的治疗策略可能因PROs滞后而导致不必要的DMARDs调整。
- 早期RA达到低疾病状态和缓解的时间普遍短于已确立RA(疲劳除外)。
核心结论
- 基于PROs的低疾病状态或缓解所需时间显著长于基于肿胀关节数的缓解时间。
- 以复合目标治疗RA可能导致不恰当的DMARDs调整。
研究设计与样本
- 基于Ontario Best Practices Research Initiative(OBRI)注册队列的回顾性分析。
- 纳入基线未达低疾病状态且随访≥6个月的986例RA患者,年龄57.4(12.9)岁,病程8.3(9.9)年,80%为女性。
主要发现
- 达到CDAI≤10、SJC28≤2、PtGA≤2cm、疼痛≤2cm和疲劳≤2cm的中位时间(95%CI)分别为12.4(11.4,13.6)、9(8.2,10)、18.9(16.1,22)、24.5(19.4,30.5)和30.4(24.8,31.7)个月。
- 达到CDAI≤2.8、SJC28≤1、PtGA≤1cm、疼痛≤1cm和疲劳≤1cm的中位时间(95%CI)分别为46.5(42,54.1)、12.5(11.4,13.4)、39.6(34.6,44.8)、54.7(43.6,57.5)和42.6(36.8,48)个月。
- 早期RA达到低疾病状态和缓解的时间普遍显著短于已确立RA,但疲劳除外。
关键数值与推荐
- 低疾病状态定义:CDAI≤10、SJC28≤2、PtGA≤2cm、疼痛评分≤2cm或疲劳≤2cm。
- 缓解定义:CDAI≤2.8、SJC28≤1、PtGA≤1cm、疼痛评分≤1cm或疲劳≤1cm。
临床怎么用
- 临床以复合指标(含PtGA)为目标时,需注意PROs缓解滞后于关节炎症控制,避免因PROs未达标而过早调整DMARDs。
- 评估RA缓解时应区分关节炎症指标与患者报告结局,结合二者综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: RA patients are often not in remission due to patient global assessment of disease activity (PtGA) included in disease activity indices. The aim was to assess the lag of patient-reported outcomes (PROs) after remission measured by clinical disease activity index (CDAI) or swollen joint count (SJC28). METHODS: RA patients enrolled in the Ontario Best Practices Research Initiative registry not in low disease state at baseline with at ≥6 months of follow-up, were included. Low disease state was defined as CDAI ≤ 10, SJC28 ≤ 2, PtGA ≤ 2cm, pain score ≤ 2cm, or fatigue ≤ 2cm. Remission included CDAI ≤ 2.8, SJC28 ≤ 1, PtGA ≤ 1cm, pain score ≤ 1cm, or fatigue ≤ 1cm. Time to first low disease state/remission based on each definition was calculated overall and stratified by early vs established RA. RESULTS: A total of 986 patients were included (age 57.4 (12.9), disease duration 8.3 (9.9) years, 80% women). The median (95% CI) time in months to CDAI ≤ 10 was 12.4 (11.4, 13.6), SJC28 ≤ 2 was 9 (8.2, 10), PtGA ≤ 2cm was 18.9 (16.1, 22), pain ≤ 2cm was 24.5 (19.4, 30.5), and fatigue ≤ 2cm was 30.4 (24.8, 31.7). For remission, the median (95% CI) time in months to CDAI ≤ 2.8 was 46.5 (42, 54.1), SJC28 ≤ 1 was 12.5 (11.4, 13.4), PtGA ≤ 1cm was 39.6 (34.6, 44.8), pain ≤ 1cm was 54.7 (43.6, 57.5) and fatigue ≤ 1cm was 42.6 (36.8, 48). Time to achieving low disease state and remission was generally significantly shorter in early RA compared with established RA with the exception of fatigue. CONCLUSION: Time to achieving low disease state or remission based on PROs was considerably longer compared with swollen joint count. Treating to a composite target in RA could lead to inappropriate changes in DMARDs.
引用
- Pope JE, Rampakakis E, Movahedi M, et al. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI). Rheumatology (Oxford). 2021. PMID: 32789456. doi:10.1093/rheumatology/keaa343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。